US equities
|
MU
$1,082.24
▲+3.51%
SNDK
$1,732.76
▲+4.35%
NVDA
$237.03
▼-0.92%
AMD
$642.87
▼-1.01%
SPCX
$168.34
▼-2.08%
INTC
$113.32
▲+0.73%
TSLA
$375.87
▼-1.26%
AAPL
$334.97
▲+0.40%
MU
$1,082.24
▲+3.51%
SNDK
$1,732.76
▲+4.35%
NVDA
$237.03
▼-0.92%
AMD
$642.87
▼-1.01%
SPCX
$168.34
▼-2.08%
INTC
$113.32
▲+0.73%
TSLA
$375.87
▼-1.26%
AAPL
$334.97
▲+0.40%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NYSEMKT:LCTX
Recent news which mentions NYSEMKT:LCTX
LCTX Stock Earnings: Lineage Cell Therapeutics Meets EPS, Beats Revenue for Q1 2024
May 09, 2024
Tickers
LCTX
Tags
LCTX
NYSEMKT:LCTX
Market News
From
InvestorPlace
LCTX Stock Earnings: Lineage Cell Therapeutics Beats EPS, Beats Revenue for Q4 2023
March 07, 2024
Tickers
LCTX
Tags
Market News
NYSEMKT:LCTX
LCTX
From
InvestorPlace
LCTX Stock Earnings: Lineage Cell Therapeutics Beats EPS, Beats Revenue for Q4 2023
March 07, 2024
Tickers
LCTX
Tags
Market News
NYSEMKT:LCTX
LCTX
From
InvestorPlace